Nalaganje...
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
PTEN expression is lost in many cancers, and even small changes in PTEN activity affect susceptibility and prognosis in a range of highly aggressive malignancies, such as melanoma and triple-negative breast cancer (TNBC). Loss of PTEN expression occurs via multiple mechanisms, including mutation, tr...
Shranjeno v:
| izdano v: | Mol Ther Nucleic Acids |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Gene & Cell Therapy
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348769/ https://ncbi.nlm.nih.gov/pubmed/30654190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2018.12.003 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|